How much is a share of tpiv worth?
One share of TPIV stock can currently be purchased for approximately $8.34. What is TapImmune's official website? The official website for TapImmune is www.tapimmune.com.
Will tpiv outperform or underperform the S&P 500 over the long term?
Vote “Outperform” if you believe TPIV will outperform the S&P 500 over the long term. Vote “Underperform” if you believe TPIV will underperform the S&P 500 over the long term. You may vote once every thirty days.
Is tapimmune's stock a good dividend growth stock to buy?
TapImmune does not have a long track record of dividend growth. In the past three months, TapImmune insiders have not sold or bought any company stock. Only 3.30% of the stock of TapImmune is held by insiders. Only 10.85% of the stock of TapImmune is held by institutions.
How were TapImmune's earnings last quarter?
TapImmune, Inc. (NASDAQ:TPIV) issued its quarterly earnings data on Thursday, August, 9th. The company reported ($0.41) earnings per share (EPS) fo...
Who are TapImmune's key executives?
TapImmune's management team includes the following people: Peter L. Hoang , President, Chief Executive Officer & Director Anthony H. Kim , Chief...
Who are some of TapImmune's key competitors?
Some companies that are related to TapImmune include Acusphere (ACUS) , Affymax (AFFY) , Alseres Pharmaceuticals (ALSE) , American Oriental Bio...
What other stocks do shareholders of TapImmune own?
Based on aggregate information from My MarketBeat watchlists, some companies that other TapImmune investors own include Verastem (VSTM) , Viking...
What is TapImmune's stock symbol?
TapImmune trades on the NASDAQ under the ticker symbol "TPIV."
What is TapImmune's stock price today?
One share of TPIV stock can currently be purchased for approximately $8.34.
What is TapImmune's official website?
The official website for TapImmune is www.tapimmune.com .
How can I contact TapImmune?
TapImmune's mailing address is 5 West Forsyth Street Suite 200, Jacksonville FL, 32202 . The company can be reached via phone at (713) 400-6400...
What is TapImmune's stock price today?
What other stocks do shareholders of TapImmune own?
One share of TPIV stock can currently be purchased for approximately $8.34.
Does TapImmune pay dividends?
Based on aggregate information from My MarketBeat watchlists, some companies that other TapImmune investors own include Verastem (VSTM), Viking Therapeutics (VKTX), Portola Pharmaceuticals (PTLA), Rigel Pharmaceuticals (RIGL), Coherus BioSciences (CHRS), Fate Therapeutics (FATE), Galectin Therapeutics (GALT), Cellectis (CLLS), CRISPR Therapeutics (CRSP) and Dynavax Technologies (DVAX).
TapImmune
TapImmune does not currently pay a dividend.
About TPIV
Some stock charts might currently not be supported. To try again, please refresh this page.
Signals & Forecast
Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of novel cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company was founded on October 22, 1991 and is headquartered in Houston, TX.
Support, Risk & Stop-loss
There are few to no technical positive signals at the moment. The TapImmune Inc stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average.
Is TapImmune Inc stock A Buy?
TapImmune Inc finds support from accumulated volume at $8.26 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
About TapImmune Inc
The TapImmune Inc stock holds several negative signals and despite the positive trend, we believe TapImmune Inc will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.
Golden Star Signal
TapImmune, Inc., a clinical-stage immunotherapy company, develops peptide and gene-based immunotherapeutics and vaccines for the treatment of cancer.
Top Fintech Company
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star. This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
